NCT02382328View on ClinicalTrials.gov

Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

alpha lipoic acid

comparison of 600mg/24h oral, alpha lipoid acid, 28 days before and 120 days after surgery (carpal tunnel release) versus placebo in carpal tunnel syndrome patients.

DRUG

Placebo

Placebo oral pills, 28 days before and 120 days after surgery (carpal tunnel release) versus placebo in carpal tunnel syndrome patients.

Trial Locations (1)

44280

Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

All Listed Sponsors
lead

Hospital Civil de Guadalajara

OTHER

NCT02382328 - Alpha Lipoic Acid on Clinical and Electrophysiological Recovery in Carpal Tunnel Syndrome Undergoing Surgical Release | Biotech Hunter | Biotech Hunter